Palladium(II) Complexes of C2-Bridged Chiral Diphosphines
2H), 5.48 (s, -C=CH-, 1H]; 13C NMR (CDCl3, 100 MHz):
d=13.98, 21.93, 22.85, 25.40, 29.77, 39.60, 63.55, 78.22 (q,
(CDCl3, 100 MHz): d=13.79, 28.91, 30.79, 36.49, 63.64, 77.97
(q, JC,F =28.0 Hz), 108.84, 123.50 (q, JC,F =287.5 Hz), 150.46,
169.78; 19F{1H} NMR (CDCl3, 376 MHz): d=À79.56; HR-
MS (ESI): m/z=291.1166, calcd. for C12H19F3O3Na [M+
Na]+: 291.1179. The enantiomeric excess was determined by
GC using a Varian CP7502 column (508C for 2 min; ramp
to 1108C at 108CminÀ1 and hold 20 min; then ramp to
1808C at 108CminÀ1 and hold 5 min, gas flow: 1 mLminÀ1):
Rt of the major enantiomer=13.0 min, Rt of the minor enan-
tiomer=13.7 min.
J
C,F =28.5 Hz), 123.38 (q, JC,F =286.3 Hz), 127.69, 130.88,
169.73; 19F{1H} NMR (CDCl3, 376 MHz) d=À78.73; HR-
MS (ESI): m/z=289.1011, calcd. for C12H17F3O3Na [M+
Na]+: 289.1022. The enantiomeric excess was determined by
GC using a Varian CP7502 column [508C for 2 min; ramp to
1108C at 108CminÀ1 and hold 30 min; then ramp to 1808C
at 108CminÀ1 and hold 20 min, gas flow: 1 mLminÀ1); Rt of
the major enantiomer=23.4 min, Rt of the minor enantio-
mer=25.5 min.
Ethyl 2-Hydroxy-6,6-dimethyl-4-methylene-2-(tri-
fluoromethyl)-heptanoate (4d)
Ethyl 2-Hydroxy-5-methyl-4-methylene-2-(trifluoro-
methyl)-hexanoate (4b) and Ethyl 2-Hydroxy-4,5-
dimethyl-2-(trifluoromethyl)-4-hexenoateACTHNUGTRNEUNG( 4b’)
The title compound was prepared according to the general
procedure using 0.25 mmol of ethyl trifluoropyruvate and
0.25 mmol of 2,4,4-trimethyl-1-pentene. The pure product
was obtained by column chromatography over silica gel
eluted with hexane/ethyl acetate (15:1). 1H NMR (CDCl3,
The title compounds were prepared according to the general
procedure using 0.25 mmol of ethyl trifluoropyruvate and
0.25 mmol of 2,3-dimethyl-1-butene. The products of two
couples of enantiomers were obtained by column chroma-
tography over silica gel eluted with hexane/ethyl acetate
400 MHz): d=0.83 [s, C
J=7.2 Hz), 1.81 [d, CH2-C
CH2-C(CH3)3, 1H, J=13.1 Hz], 2.57 [dd, CH2-C(OH), 1H,
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
1
(15:1). H NMR (CDCl3, 400 MHz, mixture of 4b and 4b’):
J=14.1 Hz, J=0.7 Hz], 2.68 [d, CH2-C(OH), 1H, J=
14.1 Hz], 3.77 (broad, -OH, 1H), 4.19–4.34 (m, COOCH2,
2H), 4.81 (t, C=CH2, 1H, J=0.8 Hz), 4.95 (s, C=CH2, 1H);
13C NMR (CDCl3, 100 MHz): d=13.91, 29.66, 31.68, 38.39,
d=0.937 (d, CHCH3 of 4b, 3H, J=6.8 Hz), 0.943 (d,
CHCH3 of 4b, 3H, J=6.8 Hz), 1.24–1.28 (m, CH2CH3 of 4b
and 4b’), 1.57 (s, CH3 of 4b’, 3H), 1.59 (s, CH3 of 4b’, 3H),
1.62 (s, CH3 of 4b’, 3H), 2.22 [sept, CHACTHUNGTRNEUNG(CH3)2 of 4b, 1H, J=
50.39, 63.64, 78.35 (q, JC,F =28.2 Hz), 118.29, 123.32 (q, JC,F
=
6.8 Hz], 2.59, 2.67, 2.76 (d,d,d, CH2 of 4b and 4b’, J=
14.5 Hz, J=14.3 Hz, J=14.1 Hz), 3.64 (s broad, OH of 4b’,
1H), 3.79 (s broad, OH of 4b, 1H), 4.12–4.36 (m, OCH2 of
4b and 4b’), 4.80 (s, C=CH2 of 4b, 1H), 4.85 (s, C=CH2 of
286.5 Hz), 140.36, 169.51; 19F{1H} NMR (CDCl3, 376 MHz):
d=À78.85; HR-MS (ESI): m/z=305.1325, calcd. for
C13H21F3O3Na [M+Na]+: 305.1335. The enantiomeric excess
was determined by GC using a Varian CP7502 column
(508C for 2 min; ramp to 1108C at 108CminÀ1 and hold
20 min; then ramp to 1808C at 108CminÀ1 and hold 5 min,
gas flow: 1 mLminÀ1): Rt of the major enantiomer=
15.5 min, Rt of the minor enantiomer=16.5 min.
1
4b, 1H). The ratio of 4b to 4b’ calculated from H NMR is
2.5. 13C NMR (CDCl3, 100 MHz, mixture of 4b and 4b’):
data of 4b: d=13.83, 21.37, 21.81, 34.11, 35.66, 63.62, 78.22
(q, JC,F =28.4 Hz), 111.56, 123.37 (q, JC,F =286.7 Hz), 148.95,
169.51; data of 4b’: d=13.76, 19.38, 20.91, 20.97, 36.18,
63.50, (a group of small peaks are hidden in between the
strong solvent peaks, its d and J cannot be accurately calcu-
lated), 119.80, 123.60 (q, JC,F =286.1 Hz), 131.58, 170.09;
19F{1H} NMR (CDCl3, 376 MHz, mixture of 4b and 4b’): d=
À78.66 (4b’), À79.02 (4b); HR-MS (ESI): m/z=277.1009,
calcd. for C11H17F3O3Na [M+Na]+: 277.1022. The enantio-
meric excess was determined by GC using a Varian CP7502
column (508C for 2 min; ramp to 1108C at 108CminÀ1 and
hold 20 min; then ramp to 1808C at 108CminÀ1 and hold
5 min, gas flow: 1 mLminÀ1): for product 4b, Rt of the major
enantiomer=10.8 min, Rt of the minor enantiomer=
11.1 min; for product 4b’, Rt of the major enantiomer=
12.6 min, Rt of the minor enantiomer=13.1 min.
Ethyl 2-Hydroxy-4-phenyl-2-(trifluoromethyl)pent-4-
enoate (4e)
The title compound was prepared according to the general
procedure using 0.25 mmol of ethyl trifluoropyruvate and
0.25 mmol of a-methylstyrene. The pure product was ob-
tained by column chromatography over silica gel eluted with
hexane/ethyl acetate (15:1). 1H NMR (CDCl3, 400 MHz):
d=1.03 (t, OCH2CH3, 3H, J=7.2 Hz), 2.96 [dd, CH2-
C(OH), 1H, J=14.0 Hz, J=0.7 Hz], 3.21 [d, CH2-C(OH),
1H, J=14.0 Hz], 3.51–3.59 (m, COOCH2, 1H), 3.72 (s,
broad, OH, 1H), 3.91–3.99 (m, COOCH2, 1H), 5.21 (d, C=
CH2, 1H, J=0.9 Hz), 5.31 (d, C=CH2, 1H, J=1.3 Hz), 7.18–
7.25 (m, Ph-H, 5H); 13C NMR (CDCl3, 100 MHz): d=13.55,
37.03 (q,
JC,F =1.1 Hz), 63.49, 77.11 (q, JC,F =28.7 Hz),
Ethyl 2-Hydroxy-5,5-dimethyl-4-methylene-2-(tri-
fluoromethyl)-hexanoate (4c)
119.45, 123.38 (q, JC,F =286.1 Hz), 126.78, 127.73, 128.16,
141.02, 141.04, 168.95; 19F{1H} NMR (CDCl3, 376 MHz): d=
À78.62; HR-MS (ESI): m/z=311.0857, calcd. for
C14H15F3O3Na [M+Na]+: 311.0866. The enantiomeric excess
was determined by HPLC with a Chiralpak AS-H column
(0.5% 2-propanol in hexane, flow 0.3 mLminÀ1): Rt of the
major enantiomer=16.0 min, Rt of the minor enantiomer=
17.2 min).
The title compound was prepared according to the general
procedure using 0.25 mmol of ethyl trifluoropyruvate and
0.25 mmol of 2,3,3-trimethyl-1-butene. The pure product was
obtained by column chromatography over silica gel eluted
with hexane/ethyl acetate (15:1). 1H NMR (CDCl3,
400 MHz): d=1.06 [s, CACHTUNTRGNENG(U CH3)3, 9H], 1.30 (t, OCH2CH3, 3H,
J=7.2 Hz), 2.66 [dt, CH2C(OH), 1H, J=16.5 Hz, J=
1.5 Hz], 2.80 [d, CH2C(OH), 1H, J=16.5 Hz], 3.88 (broad,
OH, 1H), 4.22–4.39 (m, COOCH2, 2H), 4.94 (t, C=CH2,
1H, J=1.2 Hz), 4.97 (d, C=CH2, 1H, J=1.3 Hz); 13C NMR
Adv. Synth. Catal. 2010, 352, 1356 – 1364
ꢂ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1363